Torasemide, also known as torsemide, is a diuretic medication used to treat fluid overload due to heart failure, kidney disease, and liver disease. It is a less preferred treatment for high blood pressure. It is taken by mouth or by injection into a vein. Pharmacologically torasemide is a loop diuretic that inhibits the Na+-K+-2Cl- cotransporter in the thick ascending limb of the loop of Henle, producing natriuresis and diuresis; it has higher and more consistent oral bioavailability than some older loop diuretics, substantial plasma protein binding, hepatic metabolism with renal and fecal excretion of parent and metabolites, and an elimination half life that typically supports once daily dosing in many patients. Clinical use requires monitoring of volume status, electrolytes and renal function. Typical oral dose ranges are individualized by indication and renal function and common tablet strengths include 5 mg, 10 mg and 20 mg; dose adjustment is routine in renal impairment and in patients taking other antihypertensives or nephrotoxic agents.
Parent: Torsemide
Active pharmaceutical ingredient quality control for torasemide uses validated chromatographic methods to quantify related substances and degradation products; specifications commonly set limits for identified related compounds and for unspecified impurities to ensure safety and batch-to-batch consistency. Typical acceptance criteria used by manufacturers and in many regulatory dossiers are individual identified impurities at or below 0.10 to 0.20 percent of the API and total impurities not to exceed approximately 0.50 percent, with reporting and qualification thresholds established per ICH guidance and product maximum daily dose. Known related compounds reported in stability and synthetic route studies include N-oxide and hydroxylated derivatives, desmethyl-related species and lactam-type degradants; limits for any specific related substance and the complete impurity profile are defined in the drug substance specification and are controlled by validated synthesis, purification and stability protocols.
Torasemide is used to reduce fluid overload in conditions such as congestive heart failure, chronic kidney disease with edema, and cirrhosis with ascites; it is sometimes used as an adjunct for blood pressure control but it is not a first line antihypertensive. Therapy requires monitoring of electrolytes, fluid status and kidney function.
No, Lasix is the brand name for furosemide, a different loop diuretic. Both agents inhibit the Na+-K+-2Cl- transporter and are used to treat edema, but they are distinct chemical entities with different pharmacokinetic properties, dosing regimens and bioavailability; substitution should be made only under clinical guidance.
